BioNTech announced plans to shut down three German manufacturing sites affecting up to 1,860 jobs after failing to secure buyers. The restructuring marks a shift away from pandemic era production as vaccine manufacturing moves to partner Pfizer.
BIONTECH SE-ADR will close three facilities in Germany after failing to find buyers, cutting up to 1,860 jobs. The restructuring marks a definitive pivot away from pandemic-era manufacturing. Production of its COVID-19 vaccine is shifting to partner PFIZER INC.
Everything you use on the web — faster, and in your pocket.
